Lawsuit Over UnitedHealth Group’s AI Strategy Corroborates Home Health Providers’ Convener Claims

A class action lawsuit has been filed against UnitedHealth Group (NYSE: UNH) in Minnesota. That lawsuit pertains to two issues that home health providers have long griped over: algorithms dictating care, and conveners’ role in between payers and providers. The lawsuit follows an investigation from STAT News, which alleged that UnitedHealth Group – through naviHealth […]

CMS Keeps Home Health Providers In Payment Purgatory With 2024 Final Rule, Strikes Contentious Tone With Industry

After the U.S. Centers for Medicare & Medicaid Services (CMS) released its CY 2024 final payment rule Wednesday, home health providers found themselves in a position they know all too well. Is a 0.8% aggregate payment increase better than the 2.2% decrease that was proposed? Of course. Was the rule, in its totality, effective in […]

With Optum Acquisition Pending, Amedisys Continues To Grow Non-Medicare, High-Acuity Care Revenue

Amedisys Inc. (Nasdaq: AMED) continues to make significant process in its high-acuity care business through its subsidiary Contessa Health. The company posted its third-quarter earnings late Tuesday, which highlighted 35% year-over-year growth in the high-acuity care segment. Overall, Amedisys admitted 580 high-acuity patients in the quarter in 11 JV markets. The high-acuity care segment, as […]

Controlling The Controllables: Home Health Giants Improving MA Contracts, Staffing Amid Rate Cuts

The odds are stacked against home health providers. Even while more care is heading to the home, providers have three fundamental problems. The first is that there is an insufficient workforce to meet demand. The second and third are both rate-related. The Centers for Medicare & Medicaid Services (CMS) is actively reducing home health reimbursement […]

What An Amedisys-LHC Group Combination Under Optum Would Mean For The Home Health Market

Amedisys Inc. (Nasdaq: AMED) disclosed Monday that UnitedHealth Group’s (NYSE: UNH) Optum submitted an acquisition bid. That makes for a competition between Optum and Amedisys’ current merger partner, Option Care Health (Nasdaq: OPCH). At this point, it’s unclear whether Optum will ultimately land Amedisys, though early analyst comments suggest Optum’s bid may be more favorable […]

[Updated] UnitedHealth Group’s Optum Makes Bid For Home Health Giant Amedisys

UnitedHealth Group’s (NYSE: UNH) Optum has made an unsolicited proposal to acquire all of the outstanding shares of Amedisys’ common stock in an all-cash transaction for $100 per share, the latter announced Monday morning. This could represent a “superior proposal” to Option Care Health’s (Nasdaq: OPCH) proposed deal for Amedisys. Option Care Health and Amedisys […]